ScholarLens Back to search
2002•Zhongguo linchuang xinlixue zazhiRequires access

Effect of Haloperidol and Risperidone on the Life Quality of the Patients with Schizophrenia

Ren Qing-tao

Open publisher page 0 citations

Abstract

Objective: To compare the effects between haloperidol and rieperidone on quality of life in patients with schizophrenia. Methods: The patients with schizophrenia treated respectively by haloperidol and risperidone were compared by double blind method. The General Quality of Life Inventory (GQOLI) was used to evaluate the life quality, while the Positive and Negative Symptoms Scale (PANSS) and the Treatment Emergent Symptom Scale (TESS) were used to assess the efficacy and side effects. Results: The risperidone group showed better effects than the haloperidol group in the domains of physical function ,mental health and social function The difference was significant (P0.01). Conclusion: The quality of life of Schizophrenic patients treated by haloperidol were poorer than that of risperidone.

About this research paper

What this paper is about

Objective: To compare the effects between haloperidol and rieperidone on quality of life in patients with schizophrenia. Methods: The patients with schizophrenia treated respectively by haloperidol and risperidone were compared by double blind method. The General Quality of Life Inventory (GQOLI) was used to evaluate the life quality, while the Positive and Negative Symptoms Scale (PANSS) and the Treatment Emergent Symptom Scale (TESS) were used to assess the efficacy and side effects. Results: The risperidone group showed better effects than the haloperidol group in the domains of physical function ,mental health and social function The difference was significant (P0.01). Conclusion: The quality of life of Schizophrenic patients treated by haloperidol were poorer than that of risperidone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To compare the effects between haloperidol and rieperidone on quality of life in patients with schizophrenia. Methods: The patients with schizophrenia treated respectively by haloperidol and risperidone were compared by double blind method. The General Quality of Life Inventory (GQOLI) was used to evaluate the life quality, while the Positive and Negative Symptoms Scale (PANSS) and the Treatment Emergent Symptom Scale (TESS) were used to assess the efficacy and side effects. Results: The risperidone group showed better effects than the haloperidol group in the domains of physical function ,mental health and social function The difference was significant (P0.01). Conclusion: The quality of life of Schizophrenic patients treated by haloperidol were poorer than that of risperidone.

Key concepts: Haloperidol, Risperidone, Schizophrenia (object-oriented programming), Psychology, Quality of life (healthcare), Psychiatry, Significant difference, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effect of Haloperidol and Risperidone on the Life Quality of the Patients with Schizophrenia — Research Paper | ScholarLens